Harold Eugene Brakewood, Chief Business Officer at Immuneering Corp (IMRX), bought 1,900 shares at $2.53 ($5K) on 2025-06-20, disclosed to the SEC on 2025-06-24.
Open-market purchase of $5k IMRX by Chief Business Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |